SMTL ID : 3rmf.1

CDK2 in complex with inhibitor RC-2-33

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.75 Å

Oligo State

monomer

Ligands

1 x 20Z: 4-{[4-amino-5-(naphthalen-2-ylcarbonyl)-1,3-thiazol-2-yl]amino}benzenesulfonamide(Non-covalent)

20Z.1: 17 residues within 4Å: Chain A: I.18, G.21, V.26, A.39, V.72, F.88, E.89, F.90, L.91, H.92, Q.93, D.94, K.97, Q.139, L.142, A.152, D.153 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:V.26, A:V.26, A:F.90, A:D.94, A:D.153 Hydrogen bonds: A:E.89, A:L.91, A:L.91, A:D.94, A:D.94, A:K.97 Water bridges: A:K.97

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Schonbrunn, E. et al., Development of highly potent and selective diaminothiazole inhibitors of cyclin-dependent kinases. J.Med.Chem. (2013)

Release Date

2012-10-31

Peptides

Cyclin-dependent kinase 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Cyclin-dependent kinase 2

Related Entries With Identical Sequence